1. A Treat to Target Approach Decreases the Rate of CD‐Related Adverse Outcomes versus a Clinical Approach in Patients With Moderate to Severely Active Crohn's Disease: Data From CALM2017 ACG Governors Award for Excellence in Clinical Research: 598. (October 2017) Authors: Colombel, Jean‐Frederic; Panaccione, Remo; Bossuyt, Peter; Baert, Filip; Vanasek, Tomas; Danalioglu, Ahmet; Novacek, Gottfried; Armuzzi, Alessandro; Hebuterne, Xavier; Travis, Simon; Danese, Silvio; Reinisch, Walter; Sandborn, William J.; Rutgeerts, Paul; Hommes, Daniel; Schreiber, Stefan; Neimar... Journal: American journal of gastroenterology Issue: Volume 112(2017)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Adalimumab Therapy Achieves Clinical Remission and Response at Week 26 in Chinese Patients With Crohn's Disease: 1874. (October 2015) Authors: Wallace, Kori; Wu, Kai‐Chun; Ran, Zhi Hua; Gao, Xiang; Chen, Minhu; Zhong, Jie; Sheng, Jian‐Qiu; Kamm, Michael; Travis, Simon; Robinson, Anne; Shapiro, Marisa; Li, Yao; Thakkar, Roopal Journal: American journal of gastroenterology Issue: Volume 110(2015)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Correlation of Stool Frequency and Abdominal Pain Measures With Simple Endoscopic Score for Crohn's Disease. Issue 2 (23rd October 2019) Authors: Lewis, James D; Rutgeerts, Paul; Feagan, Brian G; D'haens, Geert; Danese, Silvio; Colombel, Jean-Frederic; Reinisch, Walter; Rubin, David T; Selinger, Christian; Bewtra, Meenakshi; Barcomb, Lisa; Lacerda, Ana P; Wallace, Kori; Butler, James W; Wu, Meijing; Zhou, Qian; Liao, Xiaomei; Sandborn, Wil... Journal: Inflammatory bowel diseases Issue: Volume 26:Issue 2(2020) Page Start: 304 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Early Symptom Improvement With Risankizumab Treatment in Patients With Moderately to Severely Active Crohn's Disease: Analysis From a Phase 2 Study: 834. (October 2019) Authors: Feagan, Brian G.; Sandborn, William J.; D'Haens, Geert R.; Panés, Julian; Kaser, Arthur; Ferrante, Marc; Louis, Edouard; Dewit, Olivier; Seidler, Ursula; Kim, Kyung‐Jo; Kligys, Kristina; Wallace, Kori; Liao, Xiaomei; Lee, Wan‐Ju; Neurath, Markus F. Journal: American journal of gastroenterology Issue: Volume 114 (2019)ACG Abstracts 1:Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Effect of risankizumab on health‐related quality of life in patients with Crohn's disease: results from phase 3 MOTIVATE, ADVANCE and FORTIFY clinical trials. Issue 5 (20th October 2022) Authors: Peyrin‐Biroulet, Laurent; Ghosh, Subrata; Lee, Scott D.; Lee, Wan‐Ju; Griffith, Jenny; Wallace, Kori; Berg, Sofie; Liao, Xiaomei; Panes, Julian; Loftus, Edward V.; Louis, Edouard Journal: Alimentary pharmacology & therapeutics Issue: Volume 57:Issue 5(2023) Page Start: 496 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial. Issue 10114 (23rd December 2017) Authors: Colombel, Jean-Frederic; Panaccione, Remo; Bossuyt, Peter; Lukas, Milan; Baert, Filip; Vaňásek, Tomas; Danalioglu, Ahmet; Novacek, Gottfried; Armuzzi, Alessandro; Hébuterne, Xavier; Travis, Simon; Danese, Silvio; Reinisch, Walter; Sandborn, William J; Rutgeerts, Paul; Hommes, Daniel; Schreiber, S... Journal: Lancet Issue: Volume 390:Issue 10114(2017) Page Start: 2779 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Efficacy and Safety of Dose Escalation to Adalimumab 80 Mg Every Other Week in Japanese Patients With Crohn's Disease Who Lost Response to Maintenance Therapy: 1873. (October 2015) Authors: Wallace, Kori; Motoya, Satoshi; Watanabe, Mamoru; Hibi, Toshifumi; Lazar, Andreas; Robinson, Anne; Nishimura, Yasuko; Ozawa, Morio; Eichner, Samantha; Thakkar, Roopal Journal: American journal of gastroenterology Issue: Volume 110(2015)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Long-Term Safety and Efficacy of Risankizumab Treatment in Patients with Crohn's Disease: Results from the Phase 2 Open-Label Extension Study. (2nd June 2021) Authors: Ferrante, Marc; Feagan, Brian G; Panés, Julián; Baert, Filip; Louis, Edouard; Dewit, Olivier; Kaser, Arthur; Duan, W Rachel; Pang, Yinuo; Lee, Wan-Ju; Gustafson, Dawn; Liao, Xiaomei; Wallace, Kori; Kalabic, Jasmina; D'Haens, Geert R Journal: Journal of Crohn's and colitis Issue: Volume 15:Number 12(2021) Page Start: 2001 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Long‐Term Safety and Efficacy of Risankizumab Treatment in Patients With Crohn's Disease: 3‐Year Interim Results From the Ongoing Phase 2 Open‐Label Extension Study: 806. (October 2019) Authors: Ferrante, Marc; Feagan, Brian G.; Panés, Julian; Baert, Filip; Louis, Edouard; Dewit, Olivier; Kaser, Arthur; Duan, Weijiang; Gustafson, Dawn; Liao, Xiaomei; Wallace, Kori; Kalabic, Jasmina; D'Haens, Geert R. Journal: American journal of gastroenterology Issue: Volume 114 (2019)ACG Abstracts 1:Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Operating Properties of Different Patient Reported Outcome Endpoints Combined With Endoscopic Evaluation: Data From EXTEND: 2259. (October 2015) Authors: Sandborn, William J.; Feagan, Brian; Rutgeerts, Paul; Levesque, Barrett; Khanna, Reena; Robinson, Anne; Huang, Bidan; Zhou, Qian; Read, Holly; Wallace, Kori; Lacerda, Ana; Thakkar, Roopal Journal: American journal of gastroenterology Issue: Volume 110(2015)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗